Cardiovascular Health and Longevity: How Many Years You Can Actually Buy

The longevity industry sells supplements, ice baths, peptides, sauna protocols. Most of these have weak or zero hard-endpoint evidence behind them. Meanwhile, the highest-tier cardiovascular research has been quietly building an answer to the actual longevity question — how to add years to your life — and the answer is not glamorous. It's the heart.

This article walks through what the peer-reviewed evidence actually shows about cardiovascular health and lifespan. Every claim is sourced to a Tier-1 reference. By the end you will have a quantified sense of how much each modifiable factor moves the needle — and why the ASCVD calculator above is more useful as a longevity dashboard than as a 'will I have a heart attack' alarm.

Why cardiovascular disease dominates the longevity equation

Cardiovascular disease (CVD) remains the leading global cause of death — responsible for roughly 32% of all deaths worldwide, according to WHO. Cancer is second at ≈17%. No other single category comes close. This means that any intervention that meaningfully lowers cardiovascular risk has more leverage on life expectancy than essentially any other single health behaviour.

More importantly: the genetic component of CVD risk explains only ~30% of the variance in cardiovascular events. The remaining ~70% is environmental and behavioural — i.e., modifiable. This is not the case for many of the leading cancers. Cardiovascular longevity is one of the few high-leverage health goals that responds dramatically to action.

Life's Essential 8: the AHA's longevity score

In 2022 the American Heart Association replaced its long-running 'Simple 7' with an updated 'Life's Essential 8' (LE8) framework (Lloyd-Jones et al., Circulation 2022, PMID 35766027). The framework scores eight components — four behaviours and four biological metrics — on a 0–100 scale each. The composite score gives a single number representing cardiovascular health.

How many years are actually on the table

Sun and colleagues, in BMC Medicine 2023, followed nearly 20,000 US adults through the NHANES 2005-2018 cohort linked to National Death Index records. The result is striking: participants with a high total LE8 score had 58% lower all-cause mortality and 64% lower cardiovascular-specific mortality compared to those with a low score, tracked over a median of 7.6 years.

Translated into life expectancy: Ma and colleagues in Circulation 2023 (PMID 37036905), using a NHANES-linked life-table analysis of 23,003 adults, found that moving from low to high cardiovascular health corresponds to an average of 8.9 additional years of life expectancy at age 50. Roughly 43% of that gain comes specifically from reduced cardiovascular mortality — the remainder from delayed cancer, diabetes and dementia.

Which of the 8 components moves the needle most

Not all eight components contribute equally. Analyses across the LE8 mortality literature suggest that the behavioural components — physical activity, nicotine exposure, and diet — account for a disproportionate share of the lifespan benefit. Among the biological metrics, blood pressure and glucose are the strongest single predictors of cardiovascular events.

Physical activity

A pooled analysis by Arem and colleagues in JAMA Internal Medicine 2015 (PMID 25844730), covering 661,137 adults across six studies, established the dose-response: meeting the 150 min/week guideline of moderate aerobic activity reduces all-cause mortality by roughly 31% compared with sedentary adults. The benefit continues to increase up to about 300 min/week, after which the curve flattens. Equally important: the type of activity matters less than the volume — walking, cycling, swimming and structured training all show the same effect when matched on energy expenditure.

Smoking cessation

Jha et al. NEJM 2013 (PMID 23343063) showed that smokers who quit before age 40 avoided over 90% of the excess mortality risk that current smokers face by their 70s. Even quitting at age 50 still recovered roughly 60% of the lost life expectancy. There is no other modifiable factor with this magnitude of effect at this age range.

Blood pressure control

Whelton 2017 (PMID 29133356) summarised dozens of trials: each 10 mmHg reduction in systolic BP reduces major cardiovascular events by about 20% and all-cause mortality by about 13%. The SPRINT trial showed that targeting a systolic BP of 120 (vs 140) in older high-risk adults reduced all-cause mortality by 27%.

Cholesterol management

The Cholesterol Treatment Trialists' meta-analysis (Lancet 2010) established that each 1 mmol/L (≈39 mg/dL) reduction in LDL cholesterol reduces major vascular events by ~22% — a result reproduced in dozens of statin trials. Stone et al. 2014 (PMID 24222016) translated this into the modern primary prevention guidelines.

Diet (Mediterranean & DASH)

The PREDIMED trial (Estruch et al., NEJM 2018, PMID 29897866) randomised over 7,000 adults at high cardiovascular risk to a Mediterranean diet vs control. Result: a 30% relative reduction in major cardiovascular events over 5 years. The DASH diet trial (Sacks et al., NEJM 2001) produced comparable BP reductions equivalent to monotherapy with first-line antihypertensives.

The compound effect over decades

A single year of optimal blood pressure does not extend your life. But twenty years of it does. The longevity dividend of cardiovascular health is fundamentally a compound interest story: the small, daily preserved arterial health translates into a delayed first event, which delays a cascade of downstream complications, which adds up to years and quality of life.

This is why your 10-year ASCVD risk number from the calculator above is a useful longevity dashboard. A 5% number at age 50 is not just '5% chance in 10 years' — it is also evidence that your cardiovascular trajectory is on the right curve. A 15% number says the opposite: at this trajectory, the cumulative damage is accumulating faster than the body can repair, and the next 20 years of those rates compound.

The 80/20 rule of cardiovascular longevity

Bottom line

Cardiovascular health is not a niche concern reserved for the elderly. It is the single most studied, most modifiable, and most cost-effective longevity lever available to humans today. Life's Essential 8 quantifies the dose. The ASCVD calculator above lets you see where you sit on the curve. The interventions that move you in the right direction — daily movement, no smoking, controlled blood pressure, managed lipids, Mediterranean-style eating — are the same interventions that build the healthiest 80-year-olds. Not coincidentally, they are also the cheapest.